Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Apotex Alleges Bristol/Sanofi Misled Regulators On Plavix Settlement

This article was originally published in The Pink Sheet Daily

Executive Summary

Bristol/Sanofi made oral commitments to Apotex that were not included in a written settlement, Apotex claims in court documents.

Related Content

Plavix Patent Upheld By Court, Blocking Generic Clopidogrel
Bristol Pleads Guilty To Criminal Charges To Settle DoJ Investigation Over Plavix
Sanofi/Bristol Plavix Patent Suit To Begin Against Apotex
Plavix Settlement Outcome May Make Industry Overly Cautious, Legal Experts Say
Bristol May Have Grounds For Fraud Case Against Apotex – Attorney
Apotex Seeks $4 Bil. Bond From Sanofi/Bristol At Plavix Injunction Hearing
Bristol Investigating Failed Plavix Settlement With Apotex
Bristol/Sanofi’s Plavix Settlement Denied Antitrust Clearance
Bristol/Sanofi’s Plavix Settlement Denied Antitrust Clearance
Bristol/Sanofi's Plavix Settlement Faces Justice Department Criminal Investigation





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts